Tuesday 26 September 2017
Contact US    |    Archive
PR
12 days ago

Data Monitoring Committee Gives Go Ahead in the MIV-711 Osteoarthritis Extension Study

STOCKHOLM, Sept. 14, 2017 /PRNewswire/ -- Medivir AB (Nasdaq Stockholm: MVIR) today announces that t

Read on the original site


Hashtags:   

Data

 | 

Monitoring

 | 

Committee

 | 

Gives

 | 

Ahead

 | 

the

 | 

MIV

 | 

711

 | 

Osteoarthritis

 | 
Most Popular (6 hours)

Most Popular (24 hours)

Most Popular (a week)

Categories - Countries
All News
All Countries